144 related articles for article (PubMed ID: 26616057)
1. Annexin A2 inhibits the migration of PASMCs stimulated with HPS rat serum by down-regulating the expression of paxillin.
Chen Y; Wen X; Wang Z; Zeng J; Chen B; Yang Y; Lu K; Gu J; Yi B
Biochem Biophys Res Commun; 2016 Jan; 469(1):70-75. PubMed ID: 26616057
[TBL] [Abstract][Full Text] [Related]
2. MiR-206 controls the phenotypic modulation of pulmonary arterial smooth muscle cells induced by serum from rats with hepatopulmonary syndrome by regulating the target gene, annexin A2.
Chen L; Li YS; Cui J; Ning JN; Wang GS; Qian GS; Lu KZ; Yi B
Cell Physiol Biochem; 2014; 34(5):1768-79. PubMed ID: 25427750
[TBL] [Abstract][Full Text] [Related]
3. Paxillin suppresses the proliferation of HPS rat serum treated PASMCs by up-regulating the expression of cytoskeletal proteins.
Chen Y; Yi B; Wang Z; Gu J; Li Y; Cui J; Lu K
Mol Biosyst; 2014 Apr; 10(4):759-66. PubMed ID: 24457422
[TBL] [Abstract][Full Text] [Related]
4. Requirement of miR-9-dependent regulation of Myocd in PASMCs phenotypic modulation and proliferation induced by hepatopulmonary syndrome rat serum.
Xu D; Gu JT; Yi B; Chen L; Wang GS; Qian GS; Lu KZ
J Cell Mol Med; 2015 Oct; 19(10):2453-61. PubMed ID: 26147104
[TBL] [Abstract][Full Text] [Related]
5. Effect of annexin A2 on hepatopulmonary syndrome rat serum-induced proliferation of pulmonary arterial smooth muscle cells.
Zeng J; Yi B; Wang Z; Ning J; Wang X; Lu K
Respir Physiol Neurobiol; 2013 Jan; 185(2):332-8. PubMed ID: 23059374
[TBL] [Abstract][Full Text] [Related]
6. The involvement of aquaporin 1 in the hepatopulmonary syndrome rat serum-induced migration of pulmonary arterial smooth muscle cells via the p38-MAPK pathway.
Gao J; Chen L; Zeng J; Cui J; Ning JL; Wang GS; Belguise K; Wang X; Qian GS; Lu KZ; Yi B
Mol Biosyst; 2015 Nov; 11(11):3040-7. PubMed ID: 26315345
[TBL] [Abstract][Full Text] [Related]
7. Annexin A2-modulated proliferation of pulmonary arterial smooth muscle cells depends on caveolae and caveolin-1 in hepatopulmonary syndrome.
Liao L; Zheng B; Yi B; Liu C; Chen L; Zeng Z; Gao J
Exp Cell Res; 2017 Oct; 359(1):266-274. PubMed ID: 28729092
[TBL] [Abstract][Full Text] [Related]
8. The ET-1-mediated carbonylation and degradation of ANXA1 induce inflammatory phenotype and proliferation of pulmonary artery smooth muscle cells in HPS.
He J; Yi B; Chen Y; Huang Q; Wang H; Lu K; Fu W
PLoS One; 2017; 12(4):e0175443. PubMed ID: 28414743
[TBL] [Abstract][Full Text] [Related]
9. Loss of cell polarity regulated by PTEN/Cdc42 enrolled in the process of Hepatopulmonary Syndrome.
Gao J; Yu H; Bai X; Liu C; Chen L; Belguise K; Wang X; Lu K; Hu Z; Yi B
J Cell Mol Med; 2019 Aug; 23(8):5542-5552. PubMed ID: 31144461
[TBL] [Abstract][Full Text] [Related]
10. Annexin A1 protein regulates the expression of PMVEC cytoskeletal proteins in CBDL rat serum-induced pulmonary microvascular remodeling.
Yi B; Zeng J; Wang G; Qian G; Lu K
J Transl Med; 2013 Apr; 11():98. PubMed ID: 23587191
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenic protein-2 regulates the myogenic differentiation of PMVECs in CBDL rat serum-induced pulmonary microvascular remodeling.
Liu C; Chen L; Zeng J; Cui J; Ning JN; Wang GS; Belguise K; Wang X; Qian GS; Lu KZ; Yi B
Exp Cell Res; 2015 Aug; 336(1):109-18. PubMed ID: 26071935
[TBL] [Abstract][Full Text] [Related]
12. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling.
Zhu J; Qiu J; Chen K; Wang W; Zheng S
Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071
[TBL] [Abstract][Full Text] [Related]
13. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-199a-5p Regulates the Proliferation of Pulmonary Microvascular Endothelial Cells in Hepatopulmonary Syndrome.
Zeng J; Chen L; Chen B; Lu K; Belguise K; Wang X; Yi B
Cell Physiol Biochem; 2015; 37(4):1289-300. PubMed ID: 26430741
[TBL] [Abstract][Full Text] [Related]
15. AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs.
Shen CC; Chen B; Gu JT; Ning JL; Zeng J; Yi B; Lu KZ
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):676-684. PubMed ID: 29233725
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of autophagy ameliorates pulmonary microvascular dilation and PMVECs excessive proliferation in rat experimental hepatopulmonary syndrome.
Xu D; Chen B; Gu J; Chen L; Belguise K; Wang X; Yi B; Lu K
Sci Rep; 2016 Aug; 6():30833. PubMed ID: 27480323
[TBL] [Abstract][Full Text] [Related]
17. Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells.
Liu X; Meng L; Li J; Meng J; Teng X; Gu H; Hu S; Wei Y
Acta Physiol (Oxf); 2015 Feb; 213(2):505-18. PubMed ID: 25069740
[TBL] [Abstract][Full Text] [Related]
18. Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.
Chen B; Ning JL; Gu JT; Cui J; Yang Y; Wang Z; Zeng J; Yi B; Lu KZ
Liver Int; 2015 Apr; 35(4):1373-82. PubMed ID: 25113058
[TBL] [Abstract][Full Text] [Related]
19. M2 macrophage accumulation contributes to pulmonary fibrosis, vascular dilatation, and hypoxemia in rat hepatopulmonary syndrome.
Chen B; Yang Y; Yang C; Duan J; Chen L; Lu K; Yi B; Chen Y; Xu D; Huang H
J Cell Physiol; 2021 Nov; 236(11):7682-7697. PubMed ID: 34041750
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung.
Chang CC; Wang SS; Hsieh HG; Lee WS; Chuang CL; Lin HC; Lee FY; Lee SD; Huang HC
Clin Sci (Lond); 2015 Sep; 129(6):449-60. PubMed ID: 25940601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
